Replies to post #423948 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Good article on untrustworthy clinical trials.

https://www.nature.com/articles/d41586-023-02299-w

IMO, this paper presents at least a partial explanation on how (after 50+ years of unclear or dubious results ) FDA still claim the AD Amyloid causal link is real and certain. IMO, "regulatory so called (fake) science", is now and has been ALL about CNS-clinic-industry BP $$$$$.

[kevindenver]

Combine that with Stanford president resignation and it's not a good look for the industry and/or academia.

[Steady_T]

With all that going on I can see why Missling is being very careful. Anavex is already suspect because of its novel approach to CNS disease. Plenty of reasons not to give the critics any excuse to fault the findings. Probably explains why getting a paper published on the Anavex trial results takes so long.

We saw what happened with SAVA and the papers it had published.

Thanks for bringing that link to the board.

[Schmiggins]

Yeah, that's the scary article I'd read before my posts on the Stanford President resigning....but was too lazy to relocate it for you guys! I think I mentioned that, in part maybe to that article and others like it lately, Anavex is going to get the maximum extreme vetting treatment when we come to publish our results, you can be sure of that! We would have anyhow, of course, because we are upsetting the apple cart....bigly.

I hope we didn't lose that FDA statistics guy as someone here suggested over the weekend, I see. That wouldn't seem like a good sign ....